What Happened?
Philadelphia, PA-based Excision-BioTherapeutics Appointed Lucas Jurisson as Chief of Staff
About the Company
Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
About the Person
Lucas Jurisson is Chief of Staff at Excision BioTherapeutics. Previously, Lucas held various senior HR leadership roles in the industry.
Info Source
News
Short Profile